Belldegrun Arie

SEC source: 0001437749-26-021509 · rdgdoc.xml · derivative · entry 1

Belldegrun Arie · CIK 0001296549 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Ordinary Shares · 20,000 shares

Expires 2036-06-22

F1 · derivative.exercise_date: The shares underlying the stock option will vest in equal quarterly installments over a period of one year, subject to the director's Continuous Service (as defined in the 2017 Equity Incentive Plan) through such vesting dates.

SEC source: 0001296549-26-000002 · wk-form4_1770242650.xml · derivative · entry 7

Belldegrun Arie · CIK 0001296549 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 263,033

Underlying: Common Stock · 263,033 shares

Expires not disclosed

F6 · derivative.exercise_price: Represents an award of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Companys Common Stock. The RSUs will vest in 4 successive equal annual installments over the four-year period from February 2, 2026, subject to continued service through the vesting date.

F6 · derivative.exercise_date: Represents an award of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Companys Common Stock. The RSUs will vest in 4 successive equal annual installments over the four-year period from February 2, 2026, subject to continued service through the vesting date.

F6 · derivative.expiration_date: Represents an award of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Companys Common Stock. The RSUs will vest in 4 successive equal annual installments over the four-year period from February 2, 2026, subject to continued service through the vesting date.

SEC source: 0001296549-26-000002 · wk-form4_1770242650.xml · derivative · entry 6

Belldegrun Arie · CIK 0001296549 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 929,913

Underlying: Common Stock · 929,913 shares

Expires 2036-02-02

F5 · derivative.exercise_date: 25% of the shares subject to the stock option shall vest on February 2, 2027, and the remaining shares shall vest in 36 equal monthly installments thereafter.

SEC source: 0001193125-25-204935 · ownership.xml · derivative · entry 7

Vida Ventures GP III, L.L.C. · CIK 0001855502 · 10% owner

Vida Ventures III, L.P. · CIK 0001855504 · 10% owner

Vida Ventures III-A, L.P. · CIK 0001855503 · 10% owner

Belldegrun Arie · CIK 0001296549 · 10% owner

Vida Ventures Management Co. LLC · CIK 0001905615 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By Vida Ventures III-A, L.P.

Disclosed balance after: 0

Underlying: Common Stock · 1,262 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each share of Series C Preferred Stock has no expiration date and converted automatically into Common Stock immediately prior to the Issuer's initial public offering at a conversion ratio based upon the initial price per share to the public in the Issuer's initial public offering.

F1 · derivative.exercise_date: Each share of Series C Preferred Stock has no expiration date and converted automatically into Common Stock immediately prior to the Issuer's initial public offering at a conversion ratio based upon the initial price per share to the public in the Issuer's initial public offering.

F1 · derivative.expiration_date: Each share of Series C Preferred Stock has no expiration date and converted automatically into Common Stock immediately prior to the Issuer's initial public offering at a conversion ratio based upon the initial price per share to the public in the Issuer's initial public offering.

F4 · ownership.nature: These shares are held directly by Vida Ventures III-A, L.P. ("Vida III-A"). Vida III GP is the general partner of Vida III-A and may be deemed to have voting, investment, and dispositive power with respect to these securities. The Investment Committee and each of the Investment Committee Members may be deemed to share voting, investment and dispositive power with respect to these securities. Vida III GP, the Investment Committee and each of the Investment Committee Members disclaims beneficial ownership of the securities held of record by Vida III-A, and this report shall not be deemed an admission that they are the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their pecuniary interest therein, if any.

SEC source: 0001193125-25-204935 · ownership.xml · derivative · entry 6

Vida Ventures GP III, L.L.C. · CIK 0001855502 · 10% owner

Vida Ventures III, L.P. · CIK 0001855504 · 10% owner

Vida Ventures III-A, L.P. · CIK 0001855503 · 10% owner

Belldegrun Arie · CIK 0001296549 · 10% owner

Vida Ventures Management Co. LLC · CIK 0001905615 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By Vida Ventures III, L.P.

Disclosed balance after: 0

Underlying: Common Stock · 547,648 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each share of Series C Preferred Stock has no expiration date and converted automatically into Common Stock immediately prior to the Issuer's initial public offering at a conversion ratio based upon the initial price per share to the public in the Issuer's initial public offering.

F1 · derivative.exercise_date: Each share of Series C Preferred Stock has no expiration date and converted automatically into Common Stock immediately prior to the Issuer's initial public offering at a conversion ratio based upon the initial price per share to the public in the Issuer's initial public offering.

F1 · derivative.expiration_date: Each share of Series C Preferred Stock has no expiration date and converted automatically into Common Stock immediately prior to the Issuer's initial public offering at a conversion ratio based upon the initial price per share to the public in the Issuer's initial public offering.

F2 · ownership.nature: These shares are held directly by Vida Ventures III, L.P. ("Vida III"). Vida Ventures GP III, L.L.C. ("Vida III GP") is the general partner of Vida III and may be deemed to have voting, investment, and dispositive power with respect to these securities. Arie Belldegrun, Helen Kim and Rajul Jain, are the members of the investment committee of Vida III GP (each, an "Investment Committee Member" and such committee, the "Investment Committee").

F3 · ownership.nature: (Continued from Footnote 2) The Investment Committee and each of the Investment Committee Members may be deemed to share voting, investment and dispositive power with respect to these securities. Vida III GP, the Investment Committee and each of the Investment Committee Members disclaims beneficial ownership of the securities held of record by Vida III, and this report shall not be deemed an admission that they are the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their pecuniary interest therein, if any.

SEC source: 0001193125-25-204935 · ownership.xml · nonDerivative · entry 4

Vida Ventures GP III, L.L.C. · CIK 0001855502 · 10% owner

Vida Ventures III, L.P. · CIK 0001855504 · 10% owner

Vida Ventures III-A, L.P. · CIK 0001855503 · 10% owner

Belldegrun Arie · CIK 0001296549 · 10% owner

Vida Ventures Management Co. LLC · CIK 0001905615 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By Vida Ventures III-A, L.P.

Disclosed balance after: 2,029

F4 · ownership.nature: These shares are held directly by Vida Ventures III-A, L.P. ("Vida III-A"). Vida III GP is the general partner of Vida III-A and may be deemed to have voting, investment, and dispositive power with respect to these securities. The Investment Committee and each of the Investment Committee Members may be deemed to share voting, investment and dispositive power with respect to these securities. Vida III GP, the Investment Committee and each of the Investment Committee Members disclaims beneficial ownership of the securities held of record by Vida III-A, and this report shall not be deemed an admission that they are the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their pecuniary interest therein, if any.

SEC source: 0001193125-25-204935 · ownership.xml · nonDerivative · entry 3

Vida Ventures GP III, L.L.C. · CIK 0001855502 · 10% owner

Vida Ventures III, L.P. · CIK 0001855504 · 10% owner

Vida Ventures III-A, L.P. · CIK 0001855503 · 10% owner

Belldegrun Arie · CIK 0001296549 · 10% owner

Vida Ventures Management Co. LLC · CIK 0001905615 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By Vida Ventures III, L.P.

Disclosed balance after: 880,214

F2 · ownership.nature: These shares are held directly by Vida Ventures III, L.P. ("Vida III"). Vida Ventures GP III, L.L.C. ("Vida III GP") is the general partner of Vida III and may be deemed to have voting, investment, and dispositive power with respect to these securities. Arie Belldegrun, Helen Kim and Rajul Jain, are the members of the investment committee of Vida III GP (each, an "Investment Committee Member" and such committee, the "Investment Committee").

F3 · ownership.nature: (Continued from Footnote 2) The Investment Committee and each of the Investment Committee Members may be deemed to share voting, investment and dispositive power with respect to these securities. Vida III GP, the Investment Committee and each of the Investment Committee Members disclaims beneficial ownership of the securities held of record by Vida III, and this report shall not be deemed an admission that they are the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their pecuniary interest therein, if any.

SEC source: 0001193125-25-204935 · ownership.xml · nonDerivative · entry 2

Vida Ventures GP III, L.L.C. · CIK 0001855502 · 10% owner

Vida Ventures III, L.P. · CIK 0001855504 · 10% owner

Vida Ventures III-A, L.P. · CIK 0001855503 · 10% owner

Belldegrun Arie · CIK 0001296549 · 10% owner

Vida Ventures Management Co. LLC · CIK 0001905615 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By Vida Ventures III-A, L.P.

Disclosed balance after: 1,262

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Each share of Series C Preferred Stock has no expiration date and converted automatically into Common Stock immediately prior to the Issuer's initial public offering at a conversion ratio based upon the initial price per share to the public in the Issuer's initial public offering.

F1 · price: Each share of Series C Preferred Stock has no expiration date and converted automatically into Common Stock immediately prior to the Issuer's initial public offering at a conversion ratio based upon the initial price per share to the public in the Issuer's initial public offering.

F4 · ownership.nature: These shares are held directly by Vida Ventures III-A, L.P. ("Vida III-A"). Vida III GP is the general partner of Vida III-A and may be deemed to have voting, investment, and dispositive power with respect to these securities. The Investment Committee and each of the Investment Committee Members may be deemed to share voting, investment and dispositive power with respect to these securities. Vida III GP, the Investment Committee and each of the Investment Committee Members disclaims beneficial ownership of the securities held of record by Vida III-A, and this report shall not be deemed an admission that they are the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their pecuniary interest therein, if any.

SEC source: 0001193125-25-204935 · ownership.xml · nonDerivative · entry 1

Vida Ventures GP III, L.L.C. · CIK 0001855502 · 10% owner

Vida Ventures III, L.P. · CIK 0001855504 · 10% owner

Vida Ventures III-A, L.P. · CIK 0001855503 · 10% owner

Belldegrun Arie · CIK 0001296549 · 10% owner

Vida Ventures Management Co. LLC · CIK 0001905615 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By Vida Ventures III, L.P.

Disclosed balance after: 547,648

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Each share of Series C Preferred Stock has no expiration date and converted automatically into Common Stock immediately prior to the Issuer's initial public offering at a conversion ratio based upon the initial price per share to the public in the Issuer's initial public offering.

F1 · price: Each share of Series C Preferred Stock has no expiration date and converted automatically into Common Stock immediately prior to the Issuer's initial public offering at a conversion ratio based upon the initial price per share to the public in the Issuer's initial public offering.

F2 · ownership.nature: These shares are held directly by Vida Ventures III, L.P. ("Vida III"). Vida Ventures GP III, L.L.C. ("Vida III GP") is the general partner of Vida III and may be deemed to have voting, investment, and dispositive power with respect to these securities. Arie Belldegrun, Helen Kim and Rajul Jain, are the members of the investment committee of Vida III GP (each, an "Investment Committee Member" and such committee, the "Investment Committee").

F3 · ownership.nature: (Continued from Footnote 2) The Investment Committee and each of the Investment Committee Members may be deemed to share voting, investment and dispositive power with respect to these securities. Vida III GP, the Investment Committee and each of the Investment Committee Members disclaims beneficial ownership of the securities held of record by Vida III, and this report shall not be deemed an admission that they are the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their pecuniary interest therein, if any.

SEC source: 0001437749-25-027877 · rdgdoc.xml · derivative · entry 1

Belldegrun Arie · CIK 0001296549 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Ordinary Shares · 20,000 shares

Expires 2035-08-26

F1 · derivative.exercise_date: The shares underlying the stock option will vest in equal quarterly installments over a period of one year, subject to the director's Continuous Service (as defined in the 2017 Equity Incentive Plan) through such vesting dates.

SEC source: 0001415889-25-017834 · form4-06202025_040628.xml · derivative · entry 6

Belldegrun Arie · CIK 0001296549 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 34,000 shares

Expires 2034-06-24

F3 · derivative.exercise_date: As of immediately prior to and conditioned upon the effective time of the effective time of the Merger, pursuant to the Merger Agreement, each outstanding option to purchase Shares (each, an "Option") became fully vested and exercisable, and to the extent not exercised prior to the effective time of the Merger, was cancelled and converted into the right to receive (a) an amount in cash (without interest and subject to deduction for any required withholding tax) equal to the product of (1) the excess, if any, of the Cash Amount over the exercise price per share of each such Option and (2) the number of Shares underlying such Option immediately prior to the effective time of the Merger and (b) one CVR in respect of each Share underlying such Option; provided, however, that if the exercise price per Share of any Option was equal to or greater than the Cash Amount that was then outstanding it was cancelled for no consideration.

SEC source: 0001415889-25-017834 · form4-06202025_040628.xml · derivative · entry 5

Belldegrun Arie · CIK 0001296549 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 34,000 shares

Expires 2033-06-21

F3 · derivative.exercise_date: As of immediately prior to and conditioned upon the effective time of the effective time of the Merger, pursuant to the Merger Agreement, each outstanding option to purchase Shares (each, an "Option") became fully vested and exercisable, and to the extent not exercised prior to the effective time of the Merger, was cancelled and converted into the right to receive (a) an amount in cash (without interest and subject to deduction for any required withholding tax) equal to the product of (1) the excess, if any, of the Cash Amount over the exercise price per share of each such Option and (2) the number of Shares underlying such Option immediately prior to the effective time of the Merger and (b) one CVR in respect of each Share underlying such Option; provided, however, that if the exercise price per Share of any Option was equal to or greater than the Cash Amount that was then outstanding it was cancelled for no consideration.

SEC source: 0001415889-25-017834 · form4-06202025_040628.xml · derivative · entry 4

Belldegrun Arie · CIK 0001296549 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 34,000 shares

Expires 2032-06-21

F3 · derivative.exercise_date: As of immediately prior to and conditioned upon the effective time of the effective time of the Merger, pursuant to the Merger Agreement, each outstanding option to purchase Shares (each, an "Option") became fully vested and exercisable, and to the extent not exercised prior to the effective time of the Merger, was cancelled and converted into the right to receive (a) an amount in cash (without interest and subject to deduction for any required withholding tax) equal to the product of (1) the excess, if any, of the Cash Amount over the exercise price per share of each such Option and (2) the number of Shares underlying such Option immediately prior to the effective time of the Merger and (b) one CVR in respect of each Share underlying such Option; provided, however, that if the exercise price per Share of any Option was equal to or greater than the Cash Amount that was then outstanding it was cancelled for no consideration.

SEC source: 0001415889-25-017834 · form4-06202025_040628.xml · derivative · entry 3

Belldegrun Arie · CIK 0001296549 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 20,600 shares

Expires 2031-06-21

F3 · derivative.exercise_date: As of immediately prior to and conditioned upon the effective time of the effective time of the Merger, pursuant to the Merger Agreement, each outstanding option to purchase Shares (each, an "Option") became fully vested and exercisable, and to the extent not exercised prior to the effective time of the Merger, was cancelled and converted into the right to receive (a) an amount in cash (without interest and subject to deduction for any required withholding tax) equal to the product of (1) the excess, if any, of the Cash Amount over the exercise price per share of each such Option and (2) the number of Shares underlying such Option immediately prior to the effective time of the Merger and (b) one CVR in respect of each Share underlying such Option; provided, however, that if the exercise price per Share of any Option was equal to or greater than the Cash Amount that was then outstanding it was cancelled for no consideration.

SEC source: 0001415889-25-017834 · form4-06202025_040628.xml · nonDerivative · entry 2

Belldegrun Arie · CIK 0001296549 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Bellco Legacy II Trust

Disclosed balance after: 0

F1 · shares: Disposed of pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of May 1, 2025, by and among Kronos Bio, Inc. (the "Issuer"), Concentra Biosciences, LLC ("Parent") and Concentra Merger Sub IV, Inc., a wholly owned subsidiary of Parent ("Merger Sub"). On June 18, 2025, Parent and Merger Sub completed a tender offer pursuant to the terms of the Merger Agreement for all outstanding shares of common stock of the Issuer (each, a "Share") for an offer price of (i) $0.57 per Share in cash (the "Cash Amount"), and (ii) one non-transferable contractual contingent value right (each, a "CVR"), subject to and in accordance with the terms of the Contingent Value Rights Agreement (the "CVR Agreement"), in each case, without interest, and subject to any applicable withholding taxes (the Cash Amount plus one CVR, collectively, the "Offer Price").[continues to Footnote 2]

F2 · shares: [continues from Footnote 1] Merger Sub thereafter merged with and into the Issuer, with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Parent (the "Merger"). At the effective time of the Merger, each issued and outstanding Share (other than any Excluded Shares (as such term is defined in the Merger Agreement)) was cancelled in exchange for the right to receive the Offer Price.

SEC source: 0001415889-25-017834 · form4-06202025_040628.xml · nonDerivative · entry 1

Belldegrun Arie · CIK 0001296549 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Vida Ventures, LLC

Disclosed balance after: 0

F1 · shares: Disposed of pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of May 1, 2025, by and among Kronos Bio, Inc. (the "Issuer"), Concentra Biosciences, LLC ("Parent") and Concentra Merger Sub IV, Inc., a wholly owned subsidiary of Parent ("Merger Sub"). On June 18, 2025, Parent and Merger Sub completed a tender offer pursuant to the terms of the Merger Agreement for all outstanding shares of common stock of the Issuer (each, a "Share") for an offer price of (i) $0.57 per Share in cash (the "Cash Amount"), and (ii) one non-transferable contractual contingent value right (each, a "CVR"), subject to and in accordance with the terms of the Contingent Value Rights Agreement (the "CVR Agreement"), in each case, without interest, and subject to any applicable withholding taxes (the Cash Amount plus one CVR, collectively, the "Offer Price").[continues to Footnote 2]

F2 · shares: [continues from Footnote 1] Merger Sub thereafter merged with and into the Issuer, with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Parent (the "Merger"). At the effective time of the Merger, each issued and outstanding Share (other than any Excluded Shares (as such term is defined in the Merger Agreement)) was cancelled in exchange for the right to receive the Offer Price.

SEC source: 0001737287-25-000005 · wk-form4_1738113099.xml · derivative · entry 6

Belldegrun Arie · CIK 0001296549 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,307,927

Underlying: Common Stock · 1,307,927 shares

Expires 2035-01-24

F5 · derivative.exercise_date: 25% of the shares subject to the stock option shall vest on January 24, 2026, and the remaining shares shall vest in 36 equal monthly installments thereafter.

SEC source: 0001737287-25-000005 · wk-form4_1738113099.xml · nonDerivative · entry 1

Belldegrun Arie · CIK 0001296549 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,236,816

SEC source: 0001437749-24-025299 · rdgdoc.xml · derivative · entry 1

Belldegrun Arie · CIK 0001296549 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Ordinary Shares · 10,000 shares

Expires 2034-08-06

F1 · derivative.exercise_date: The shares underlying the stock option will vest in equal quarterly installments over a period of one year, subject to the director's Continuous Service (as defined in the 2017 Equity Incentive Plan) through such vesting dates.

SEC source: 0001415889-24-018230 · form4-06262024_080619.xml · derivative · entry 1

Belldegrun Arie · CIK 0001296549 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,000

Underlying: Common Stock · 34,000 shares

Expires 2034-06-24

F1 · derivative.exercise_date: The shares subject to the option will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders.

SEC source: 0001127602-24-018717 · form4.xml · derivative · entry 5

Belldegrun Arie · CIK 0001296549 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 571,428

Underlying: Class A Common Stock · 571,428 shares

Expires 2034-06-13

F5 · shares: In accordance with the Issuer's Non-Employee Director Compensation Program, the Black-Scholes value of the option award as of the grant date is $200,000.

F4 · derivative.exercise_date: The vesting date of the RSUs and stock options, and in the case of the stock options the date they become exercisable, will be the earlier of (i) June 13, 2025 or (ii) the day immediately prior to the date of the Issuer's next Annual Meeting of Shareholders occurring after the grant date, in either case subject to the Reporting Person continuing in service as a Non-Employee Director of the Issuer through such date. The RSUs have no expiration date.

F5 · derivative.underlying_shares: In accordance with the Issuer's Non-Employee Director Compensation Program, the Black-Scholes value of the option award as of the grant date is $200,000.

SEC source: 0001127602-24-018717 · form4.xml · derivative · entry 4

Belldegrun Arie · CIK 0001296549 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 432,900

Underlying: Class A Common Stock · 432,900 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F4 · derivative.exercise_date: The vesting date of the RSUs and stock options, and in the case of the stock options the date they become exercisable, will be the earlier of (i) June 13, 2025 or (ii) the day immediately prior to the date of the Issuer's next Annual Meeting of Shareholders occurring after the grant date, in either case subject to the Reporting Person continuing in service as a Non-Employee Director of the Issuer through such date. The RSUs have no expiration date.

F4 · derivative.expiration_date: The vesting date of the RSUs and stock options, and in the case of the stock options the date they become exercisable, will be the earlier of (i) June 13, 2025 or (ii) the day immediately prior to the date of the Issuer's next Annual Meeting of Shareholders occurring after the grant date, in either case subject to the Reporting Person continuing in service as a Non-Employee Director of the Issuer through such date. The RSUs have no expiration date.

SEC source: 0001127602-24-018717 · form4.xml · derivative · entry 3

Belldegrun Arie · CIK 0001296549 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 105,263 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F3 · derivative.exercise_date: In accordance with the Issuer's Non-Employee Director Compensation Program, the RSUs granted on June 16, 2023 vested in full in Class A shares on June 12, 2024, which was the day immediately prior to the date of the Issuer's next Annual Meeting of Shareholders occurring after the grant date, and was subject to the Reporting Person continuing in service as a Non-Employee Director of the Issuer through such date.

F3 · derivative.expiration_date: In accordance with the Issuer's Non-Employee Director Compensation Program, the RSUs granted on June 16, 2023 vested in full in Class A shares on June 12, 2024, which was the day immediately prior to the date of the Issuer's next Annual Meeting of Shareholders occurring after the grant date, and was subject to the Reporting Person continuing in service as a Non-Employee Director of the Issuer through such date.

SEC source: 0001127602-24-018717 · form4.xml · nonDerivative · entry 1

Belldegrun Arie · CIK 0001296549 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 194,925

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

SEC source: 0001737287-24-000042 · primary_doc.xml · nonDerivative · entry 2

Belldegrun Arie · CIK 0001296549 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 1,724,137

F3 · shares: Consists of 1,720,172 shares of common stock acquired by Vida Ventures III, L.P. and 3,965 shares of common stock acquired by Vida Ventures III A, L.P. from Goldman Sachs (the Underwriter) in a registered direct offering.

F4 · ownership.nature: The securities are held by Vida Ventures III, L.P. and Vida Ventures III-A, L.P. Vida Ventures GP III, LLC is the manager of Vida Ventures III, L.P. and Vida Ventures III-A, L.P. The reporting person is a Senior Managing Director of Vida Ventures GP III, LLC and may therefore be deemed to be the beneficial owner of the common shares held by Vida Ventures III, L.P. and Vida Ventures III-A, L.P. The reporting person disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein.

SEC source: 0001737287-24-000042 · primary_doc.xml · nonDerivative · entry 1

Belldegrun Arie · CIK 0001296549 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 539,867

F1 · shares: These shares of common stock were acquired directly from Allogene Therapeutics, Inc (the "Issuer") in a registered direct offering.

F2 · ownership.nature: The securities are held in the name of Bellco Legacy LLC. Bellco Legacy LLC is owned and managed by trusts controlled by the reporting person and Rebecka Belldegrun.

SEC source: 0001593968-24-000194 · primary_01.xml · derivative · entry 5

Belldegrun Arie · CIK 0001296549 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 749,398

Underlying: Common Stock · 749,398 shares

Expires 2034-01-25

F4 · derivative.exercise_date: 1/3 of the shares subject to the stock option shall vest on January 25, 2025, and the remaining shares shall vest in 24 equal monthly installments thereafter.

SEC source: 0001593968-24-000194 · primary_01.xml · nonDerivative · entry 1

Belldegrun Arie · CIK 0001296549 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,866,859

SEC source: 0001437749-23-025486 · rdgdoc.xml · derivative · entry 1

Belldegrun Arie · CIK 0001296549 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Ordinary Shares · 10,000 shares

Expires 2033-09-07

F1 · derivative.exercise_date: The shares underlying the stock option will vest in equal quarterly installments over a period of one year.

SEC source: 0001209191-23-039683 · doc4.xml · derivative · entry 1

Belldegrun Arie · CIK 0001296549 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,000

Underlying: Common Stock · 34,000 shares

Expires 2033-06-21

F1 · derivative.exercise_date: The shares subject to the option will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders.

SEC source: 0001127602-23-019165 · form4.xml · derivative · entry 2

Belldegrun Arie · CIK 0001296549 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 139,860

Underlying: Class A Common Stock · 139,860 shares

Expires 2033-06-16

F3 · shares: In accordance with the Issuer's Non-Employee Director Compensation Program, the Black-Scholes value of the option award as of the grant date is $200,000.

F2 · derivative.exercise_date: The vesting date of the RSUs and stock options, and in the case of the stock options the date they become exercisable, will be the earlier of (i) June 16, 2024 or (ii) the day immediately prior to the date of the Issuer's next Annual Meeting of Shareholders occurring after the grant date, in either case subject to the Reporting Person continuing in service as a Non-Employee Director of the Issuer through such date. The RSUs have no expiration date. RSUs granted on June 10, 2022 that were initially reported as Class A Common Stock in Table I of a Form 4 dated June 13, 2022 vested in full in shares on June 10, 2023.

F3 · derivative.underlying_shares: In accordance with the Issuer's Non-Employee Director Compensation Program, the Black-Scholes value of the option award as of the grant date is $200,000.

SEC source: 0001127602-23-019165 · form4.xml · derivative · entry 1

Belldegrun Arie · CIK 0001296549 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 105,263

Underlying: Class A Common Stock · 105,263 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

F2 · derivative.exercise_date: The vesting date of the RSUs and stock options, and in the case of the stock options the date they become exercisable, will be the earlier of (i) June 16, 2024 or (ii) the day immediately prior to the date of the Issuer's next Annual Meeting of Shareholders occurring after the grant date, in either case subject to the Reporting Person continuing in service as a Non-Employee Director of the Issuer through such date. The RSUs have no expiration date. RSUs granted on June 10, 2022 that were initially reported as Class A Common Stock in Table I of a Form 4 dated June 13, 2022 vested in full in shares on June 10, 2023.

F2 · derivative.expiration_date: The vesting date of the RSUs and stock options, and in the case of the stock options the date they become exercisable, will be the earlier of (i) June 16, 2024 or (ii) the day immediately prior to the date of the Issuer's next Annual Meeting of Shareholders occurring after the grant date, in either case subject to the Reporting Person continuing in service as a Non-Employee Director of the Issuer through such date. The RSUs have no expiration date. RSUs granted on June 10, 2022 that were initially reported as Class A Common Stock in Table I of a Form 4 dated June 13, 2022 vested in full in shares on June 10, 2023.

SEC source: 0001593968-23-000523 · primary_01.xml · derivative · entry 5

Belldegrun Arie · CIK 0001296549 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 994,800

Underlying: Common Stock · 994,800 shares

Expires 2033-03-22

F5 · derivative.exercise_date: 25% of the shares subject to the stock option shall vest on March 13, 2024, and the remaining shares shall vest in 36 equal monthly installments thereafter.

SEC source: 0001593968-23-000523 · primary_01.xml · nonDerivative · entry 1

Belldegrun Arie · CIK 0001296549 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,654,886

F1 · shares: Includes 986,905 of performance RSUs which shall vest as follows: (1) 50% shall vest if the 30-day weighted average stock price is equal to or greater than $18 and (2) 50% shall vest upon the first regulatory approval of a product candidate. Notwithstanding the foregoing (1) any portion that vests upon the stock price threshold shall no longer vest and be terminated after three years from the grant date if such threshold has not been met in such three-year period, and (2) any portion that vests upon product candidate approval shall no longer vest and be terminated after five years from the grant date if such approval has not occurred in such five-year period.

SEC source: 0001437749-22-022616 · rdgdoc.xml · derivative · entry 2

Belldegrun Arie · CIK 0001296549 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 160,000 shares

Expires 2022-10-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001437749-22-022616 · rdgdoc.xml · nonDerivative · entry 1

Belldegrun Arie · CIK 0001296549 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 408,693

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001437749-22-021777 · rdgdoc.xml · derivative · entry 2

Belldegrun Arie · CIK 0001296549 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 3,241 shares

Expires 2022-09-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001437749-22-021777 · rdgdoc.xml · nonDerivative · entry 1

Belldegrun Arie · CIK 0001296549 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 248,693

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-22-039774 · doc4.xml · derivative · entry 1

Belldegrun Arie · CIK 0001296549 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,000

Underlying: Common Stock · 34,000 shares

Expires 2032-06-21

F1 · derivative.exercise_date: The shares subject to the option will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders.

SEC source: 0000899243-22-022286 · doc4.xml · derivative · entry 3

Belldegrun Arie · CIK 0001296549 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 108,516

Underlying: Class A Common Stock · 108,516 shares

Expires 2032-06-10

F3 · shares: In accordance with the Non-Employee Director Compensation Policy of the Issuer, the Black-Scholes value of the option award as of the grant date is $200,000.

F1 · derivative.exercise_date: The vesting date of the restricted stock units and stock options, and in the case of the stock options, the exercise date, will be the earlier of either June 10, 2023 or the day immediately prior to the date of the next Annual Meeting of Shareholders of the Issuer occurring after the date of grant, in either case, subject to the Reporting Person continuing in service as a Non-Employee Director through such date.

SEC source: 0000899243-22-022286 · doc4.xml · nonDerivative · entry 1

Belldegrun Arie · CIK 0001296549 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 89,662

F1 · shares: The vesting date of the restricted stock units and stock options, and in the case of the stock options, the exercise date, will be the earlier of either June 10, 2023 or the day immediately prior to the date of the next Annual Meeting of Shareholders of the Issuer occurring after the date of grant, in either case, subject to the Reporting Person continuing in service as a Non-Employee Director through such date.

SEC source: 0001437749-22-014774 · rdgdoc.xml · derivative · entry 1

Belldegrun Arie · CIK 0001296549 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Ordinary Shares · 10,000 shares

Expires 2032-06-08

F1 · derivative.exercise_date: The shares underlying the stock option will vest in equal quarterly installments over a period of one year.

SEC source: 0001214659-22-004372 · marketforms-55853.xml · derivative · entry 1

Belldegrun Arie · CIK 0001296549 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,458,333

Underlying: Common Stock · 1,458,333 shares

Expires 2032-03-23

F1 · derivative.exercise_date: 25% of the shares subject to the stock option shall vest on March 13, 2023, and the remaining shares shall vest in 36 equal monthly installments thereafter.

SEC source: 0001214659-22-004613 · marketforms-55916.xml · nonDerivative · entry 5

Belldegrun Arie · CIK 0001296549 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 4,710,121

F3 · ownership.nature: These shares were sold by Bellco Legacy IV LLC, of which the reporting person and Rebecka Belldegrun are managers, to Bellco Legacy Trust fbo Rebecka Belldegrun, of which the reporting person's spouse is trustee and beneficiary. In exchange for the shares, the reporting person received a promissory note in the principal amount of $36,032,422.83.

SEC source: 0001214659-22-004613 · marketforms-55916.xml · nonDerivative · entry 4

Belldegrun Arie · CIK 0001296549 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 0

F3 · ownership.nature: These shares were sold by Bellco Legacy IV LLC, of which the reporting person and Rebecka Belldegrun are managers, to Bellco Legacy Trust fbo Rebecka Belldegrun, of which the reporting person's spouse is trustee and beneficiary. In exchange for the shares, the reporting person received a promissory note in the principal amount of $36,032,422.83.

SEC source: 0001214659-22-004729 · marketforms-55948.xml · nonDerivative · entry 3

Belldegrun Arie · CIK 0001296549 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 4,710,120

F1 · balance_after: This amendment is being filed to correct the share holdings reported on the Form 4 filed by the reporting person on March 31, 2022.

F2 · ownership.nature: These shares were sold by Bellco Legacy IV LLC, of which the reporting person and Rebecka Belldegrun are managers, to Bellco Legacy Trust fbo Rebecka Belldegrun, of which the reporting person's spouse is trustee and beneficiary. In exchange for the shares, the reporting person received a promissory note in the principal amount of $36,032,418.00.

SEC source: 0001214659-22-004729 · marketforms-55948.xml · nonDerivative · entry 2

Belldegrun Arie · CIK 0001296549 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 0

F2 · ownership.nature: These shares were sold by Bellco Legacy IV LLC, of which the reporting person and Rebecka Belldegrun are managers, to Bellco Legacy Trust fbo Rebecka Belldegrun, of which the reporting person's spouse is trustee and beneficiary. In exchange for the shares, the reporting person received a promissory note in the principal amount of $36,032,418.00.

SEC source: 0001214659-22-000701 · marketforms-55052.xml · nonDerivative · entry 2

Belldegrun Arie · CIK 0001296549 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 195,039

F1 · price: The reported securities were purchased by Bellco Legacy LLC at an average price of $12.60 per unit, calculated from the price range of $12.35 to $13.00.

F2 · ownership.nature: The securities are held in the name of Bellco Legacy LLC. Bellco Legacy LLC is owned and managed by trusts controlled by the reporting person and Rebecka Belldegrun.

SEC source: 0001209191-21-042879 · doc4.xml · derivative · entry 1

Belldegrun Arie · CIK 0001296549 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,600

Underlying: Common Stock · 20,600 shares

Expires 2031-06-21

F1 · derivative.exercise_date: The shares subject to the option will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders.

SEC source: 0001209191-21-039131 · doc4.xml · derivative · entry 1

Belldegrun Arie · CIK 0001296549 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2031-06-06

F1 · derivative.exercise_date: The shares underlying the stock option will vest in equal quarterly installments over a period of one year.